Rocket Pharmaceuticals, Inc, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need,...
Quantum-Si Incorporated, The Protein Sequencing Company, announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors.
“Jack brings a...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...
